GI cancer resection OK with mild cirrhotic liver dysfunction

This article originally appeared here.
GI Cancer Resection OK With Mild Cirrhotic Liver Dysfunction
GI Cancer Resection OK With Mild Cirrhotic Liver Dysfunction

(HealthDay News) -- For patients with cirrhosis, resection of gastrointestinal (GI) malignancies correlates with poor early postoperative outcomes, with severity of liver disease being the primary determinant of postoperative mortality, according to a study published in the July issue of Cancer.

To examine early postoperative and transitional outcomes in cirrhotic patients undergoing GI cancer surgery, Avo Artinyan, M.D., from the Michael E. DeBakey VA Medical Center in Houston, and colleagues analyzed data from the National Inpatient Sample Database (2005 to 2008) and identified 106,729 patients who underwent resection for GI malignancy, of whom 1,479 (1.4 percent) were diagnosed with cirrhosis.

The researchers found that patients with cirrhosis had a significantly increased risk of in-hospital mortality (8.9 versus 2.8 percent), longer length of stay (11.5 ± 0.26 versus 10.0 ± 0.03 days), and higher rate of discharge to long-term care facilities (19.0 versus 15.7 percent). Patients with moderate-to-severe liver dysfunction had the highest mortality (21.5 versus 6.5 percent). Cirrhosis was an independent predictor of in-hospital mortality and non-home discharge (odds ratios [ORs], 3.0 and 1.7, respectively), in multivariate analysis. Moderate-to-severe liver dysfunction was the only independent predictor of in-hospital mortality for patients with cirrhosis (OR, 4.03).

"Resection of GI malignancy in cirrhotics is associated with poor early postoperative and transitional outcomes, with severity of liver disease being the primary determinant of postoperative mortality," the authors write. "These data suggest that GI cancer operations can be performed safely in well-selected cirrhotic patients with mild liver dysfunction."

Abstract
Full Text (subscription or payment may be required)

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs